Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Influenza Vaccination on Global Systemic Inflammatory Markers in Patients With Stable Coronary Artery Disease
NCT06508437Phase 4Completed
- Sponsor
- University Hospital Tours
- Start
- Oct 2024
- Primary completion
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine in coronary artery disease (CAD), atherosclerosis, sponsored by University Hospital Tours. Started Oct 2024; status: completed.
02
Drugs
influenza vaccine
03
Conditions
coronary artery disease (CAD)atherosclerosis
Beyond the preview
Go deeper on NCT06508437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06508437.